Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1275)
|
Core Tip (1285)
|
Full Article (HTML) (4300)
|
Full Article (PDF)-777K (671)
|
Audio-357K (37)
|
Peer-Review Report-122K (204)
|
Answering Reviewers-64K (255)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (12469)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications

World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1525)
|
Core Tip (1539)
|
Full Article (HTML) (13839)
|
Figures (1-4) (1832)
|
Full Article (PDF)-948K (1367)
|
Audio-1310K (34)
|
Peer-Review Report-106K (441)
|
Answering Reviewers-19K (295)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (61)
|
Total Visits (28678)
|
Similar Articles (503)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model

World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1402)
|
Core Tip (1406)
|
Full Article (HTML) (5217)
|
Figures (1-2) (378)
|
Tables (1-2) (367)
|
Full Article (PDF)-1246K (774)
|
Audio-442K (34)
|
Peer-Review Report-131K (372)
|
Answering Reviewers-120K (234)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (19173)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?

World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1301)
|
Core Tip (1287)
|
Full Article (HTML) (4142)
|
Figures (1-3) (402)
|
Tables (1-1) (392)
|
Full Article (PDF)-814K (574)
|
Audio-757K (29)
|
Peer-Review Report-105K (286)
|
Answering Reviewers-109K (255)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (17580)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1352)
|
Core Tip (1384)
|
Full Article (HTML) (4023)
|
Tables (1-3) (361)
|
Full Article (PDF)-799K (539)
|
Audio-1969K (21)
|
Peer-Review Report-132K (256)
|
Answering Reviewers-50K (229)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (15273)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open